

Learn about Myfembree side effects — from common issues like headache and hot flashes to serious risks. Know when to call your doctor right away.
Myfembree (Relugolix/Estradiol/Norethindrone Acetate) is a once-daily oral medication used to treat heavy menstrual bleeding from uterine fibroids and moderate to severe endometriosis pain in premenopausal women. Like all medications, it comes with potential side effects — some mild and manageable, others serious enough to require immediate medical attention.
This guide covers the most common and serious side effects of Myfembree based on FDA labeling, so you know what to expect and when to reach out to your healthcare provider.
Myfembree combines three active ingredients:
The add-back therapy is designed to lower the risk of bone loss and other estrogen-deprivation side effects. For a deeper look at what Myfembree is and how it's used, see our full guide.
The following side effects were reported in clinical trials and are generally mild to moderate. Most improve over the first few weeks or months of treatment:
Many women find that these side effects are much more manageable than the symptoms of untreated fibroids or endometriosis. Talk to your doctor if any of these become bothersome — there are often ways to manage them.
While less common, Myfembree does carry risks of more serious side effects. Some require immediate medical attention.
Myfembree's most serious warning relates to blood clots and vascular events. The estrogen and progestin components increase the risk of:
This risk is highest in women who:
Call 911 or go to the emergency room immediately if you experience:
Myfembree can cause a decrease in bone mineral density. This is why treatment is limited to 24 months — prolonged use may lead to bone loss that is not fully reversible. Your doctor may order a bone density scan (DEXA scan) before or during treatment, especially if you have other risk factors for osteoporosis.
If you smoke and are over 35, the risk of serious cardiovascular events with Myfembree is significantly higher. Your doctor may recommend quitting smoking before starting this medication or may suggest an alternative treatment.
If you have high blood pressure, diabetes, high cholesterol, or obesity, your doctor will carefully weigh the risks and benefits before prescribing Myfembree.
Myfembree is contraindicated in pregnancy. A pregnancy test is required before starting treatment. Myfembree is not a contraceptive, so you'll need to use non-hormonal birth control (such as condoms or a copper IUD) while taking it. Breastfeeding is not recommended while on Myfembree, as Relugolix passes into breast milk.
If you already have low bone density or risk factors for osteoporosis, your doctor may recommend extra monitoring or an alternative treatment. Myfembree is contraindicated in women with known osteoporosis.
Here are some practical tips for dealing with the most common Myfembree side effects:
Don't stop taking Myfembree without talking to your doctor first, even if side effects are bothering you. Your provider may be able to adjust your treatment plan or help you manage symptoms more effectively.
Most women who take Myfembree experience mild side effects that improve over time. However, because of the boxed warning about blood clots and the risk of bone loss, it's important to stay in close contact with your doctor throughout treatment.
Know the warning signs of serious side effects, keep up with your scheduled appointments, and don't hesitate to call your doctor if something doesn't feel right.
If you're ready to start Myfembree, use Medfinder to find a pharmacy near you that has it in stock. And for more information about what Myfembree is and how it works, check out our other guides.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.